5.42
전일 마감가:
$5.48
열려 있는:
$5.36
하루 거래량:
3.82M
Relative Volume:
0.62
시가총액:
$966.91M
수익:
$2.53B
순이익/손실:
$-200.32M
주가수익비율:
-4.7502
EPS:
-1.141
순현금흐름:
$133.23M
1주 성능:
-3.39%
1개월 성능:
+19.38%
6개월 성능:
-35.48%
1년 성능:
-38.55%
텔라닥 헬스 Stock (TDOC) Company Profile
명칭
Teladoc Health Inc
전화
(203) 635-2002
주소
155 E 44TH STREET, NEW YORK, NY
Compare TDOC vs VEEV, TEM, BTSG, HQY, WAY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
TDOC
Teladoc Health Inc
|
5.42 | 977.61M | 2.53B | -200.32M | 133.23M | -1.141 |
|
VEEV
Veeva Systems Inc
|
179.11 | 30.45B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
TEM
Tempus Ai Inc
|
48.83 | 8.78B | 1.27B | -245.03M | -245.36M | -1.4071 |
|
BTSG
Brightspring Health Services Inc
|
43.31 | 8.09B | 12.91B | 104.80M | 394.69M | 0.8769 |
|
HQY
Healthequity Inc
|
82.10 | 6.90B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
WAY
Waystar Holding Corp
|
24.03 | 4.72B | 1.10B | 112.09M | 283.19M | 0.6096 |
텔라닥 헬스 Stock (TDOC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2026-02-26 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-13 | 개시 | BMO Capital Markets | Market Perform |
| 2025-07-25 | 개시 | Mizuho | Neutral |
| 2024-11-15 | 개시 | Goldman | Buy |
| 2024-09-17 | 재확인 | Jefferies | Hold |
| 2024-02-29 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-17 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-04-12 | 개시 | Stephens | Equal-Weight |
| 2023-02-23 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2022-10-24 | 업그레이드 | Guggenheim | Sell → Neutral |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 개시 | Truist | Hold |
| 2022-08-17 | 다운그레이드 | Guggenheim | Neutral → Sell |
| 2022-08-12 | 개시 | DA Davidson | Buy |
| 2022-08-02 | 다운그레이드 | Berenberg | Buy → Hold |
| 2022-08-02 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2022-07-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-07-28 | 다운그레이드 | Needham | Buy → Hold |
| 2022-07-06 | 재확인 | BofA Securities | Neutral |
| 2022-05-05 | 다운그레이드 | Argus | Buy → Hold |
| 2022-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-04-28 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2022-04-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-04-28 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-28 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-28 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2022-04-07 | 개시 | Guggenheim | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Outperform |
| 2022-03-03 | 업그레이드 | Argus | Hold → Buy |
| 2022-02-23 | 재확인 | BofA Securities | Neutral |
| 2022-02-23 | 재확인 | Craig Hallum | Hold |
| 2022-02-23 | 재확인 | Evercore ISI | In-line |
| 2022-02-23 | 재확인 | Goldman | Buy |
| 2022-02-23 | 재확인 | JP Morgan | Overweight |
| 2022-02-23 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2022-02-23 | 재확인 | Needham | Buy |
| 2022-02-23 | 재확인 | Oppenheimer | Outperform |
| 2022-02-23 | 재확인 | Stifel | Hold |
| 2022-02-11 | 개시 | Goldman | Buy |
| 2022-02-08 | 재확인 | Piper Sandler | Overweight |
| 2021-12-02 | 재개 | Jefferies | Hold |
| 2021-11-22 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-28 | 재확인 | Barclays | Equal Weight |
| 2021-10-28 | 재확인 | BofA Securities | Neutral |
| 2021-10-28 | 재확인 | Canaccord Genuity | Buy |
| 2021-10-28 | 재확인 | Citigroup | Buy |
| 2021-10-28 | 재확인 | Craig Hallum | Hold |
| 2021-10-28 | 재확인 | Needham | Buy |
| 2021-10-28 | 재확인 | Oppenheimer | Outperform |
| 2021-10-28 | 재확인 | Piper Sandler | Overweight |
| 2021-10-28 | 재확인 | UBS | Neutral |
| 2021-10-19 | 개시 | Wells Fargo | Overweight |
| 2021-08-02 | 다운그레이드 | Argus | Buy → Hold |
| 2021-07-28 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2021-05-28 | 개시 | Robert W. Baird | Neutral |
| 2021-04-15 | 개시 | Needham | Buy |
| 2021-01-07 | 개시 | BTIG Research | Buy |
| 2020-12-22 | 개시 | Evercore ISI | In-line |
| 2020-12-07 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-12-04 | 개시 | Goldman | Neutral |
| 2020-11-13 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-09-22 | 개시 | DA Davidson | Buy |
| 2020-09-02 | 업그레이드 | Berenberg | Hold → Buy |
| 2020-08-17 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-07-14 | 개시 | Citigroup | Buy |
| 2020-07-13 | 개시 | Argus | Buy |
| 2020-07-07 | 개시 | Stephens | Overweight |
| 2020-04-30 | 재확인 | KeyBanc Capital Markets | Overweight |
| 2020-04-13 | 개시 | SVB Leerink | Outperform |
| 2020-03-31 | 다운그레이드 | Berenberg | Buy → Hold |
| 2020-03-25 | 다운그레이드 | Craig Hallum | Buy → Hold |
| 2020-03-16 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-28 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-10 | 개시 | UBS | Neutral |
| 2020-01-09 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
텔라닥 헬스 주식(TDOC)의 최신 뉴스
Teladoc (TDOC) Sees a More Significant Dip Than Broader Market: Some Facts to Know - Yahoo Finance Singapore
Asia Pacific Telemedicine Market Size, Share 2026 Analysis - openPR.com
Digital Health Market Is Going to Boom| Teladoc Health, American Well Corporation, and Doctor on Demand - openPR.com
3 Stocks Under $10 Walking a Fine Line - Yahoo Finance
Teladoc Health stock popshere's why - MSN
The Bull Case For Teladoc Health (TDOC) Could Change Following Mixed Guidance And Rising User GrowthLearn Why - Sahm
Teladoc Health (NYSE:TDOC) Share Price Crosses Above Fifty Day Moving AverageWhat's Next? - MarketBeat
These analysts slash their forecasts on Teladoc Health after Q4 results - MSN
Stock Momentum Analysis: Teladoc, Krispy Kreme vs. Coinbase | 2026News and Statistics - IndexBox
Virtual Healthcare Market Set to Witness Rapid Growth Through - openPR.com
TDOC News | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Telehealth Market Poised for Exceptional Growth at 31.81% CAGR - openPR.com
A Look At Teladoc Health’s Valuation After Mixed Revenue Beat And Guidance Update - Sahm
Teladoc Health Stock Analysis: Decline, Growth Stagnation, and Investment OutlookNews and Statistics - IndexBox
TDOC Stock Price, Quote & Chart | TELADOC HEALTH INC (NYSE:TDOC) - ChartMill
Jim Cramer on Teladoc: “I don’t see any reason to own it” - MSN
Teladoc (TDOC) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: NeurAxis, Inc. (NRXS), Argenx Se (ARGX) and Teladoc (TDOC) - The Globe and Mail
Digital Preventive Care Market Is Going to Boom | Major Giants - openPR.com
Technical Reactions to TDOC Trends in Macro Strategies - Stock Traders Daily
Online Marketplace Stocks Q4 In Review: Teladoc (NYSE:TDOC) Vs Peers - Yahoo Finance
Teladoc Health, Inc. drives Medicare shift to virtual diabetes prevention for older and rural adults - Traders Union
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 - Caledonian Record
JP Morgan Maintains Neutral Rating on TDOC, Lowers Price Target - GuruFocus
JPMorgan Chase & Co. Cuts Teladoc Health (NYSE:TDOC) Price Target to $7.00 - MarketBeat
Q1 EPS Estimates for Teladoc Health Lifted by Zacks Research - MarketBeat
Us Telehealth Market Set to Witness Rapid Growth Through 2033 | Teladoc Health Inc., American Well Corporation - openPR.com
Remote Healthcare Market Set to Witness Rapid Growth Through - openPR.com
Us Telemedicine Market Is Going to Boom Rapidly | Teladoc Health Inc., American Well Corporation - openPR.com
mHealth Market to Reach US$210.83 Billion by 2033 at 13.5% CAGR; - openPR.com
Teladoc Health (TDOC) Is Up 6.6% After BetterHelp Turnaround Hopes And Analyst UpgradesHas The Bull Case Changed? - Sahm
Charles Divita III Sells 27,731 Shares of Teladoc Health (NYSE:TDOC) Stock - MarketBeat
Teladoc (TDOC) executive earns 15,596 performance stock units tied to 2025 results - Stock Titan
Teladoc (NYSE: TDOC) CEO gains new stock units and sells shares for taxes - Stock Titan
TDOC SEC FilingsTeladoc Health Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Hims & Hers Plunges 29.4% in Three Months: How to Play the Stock? - The Globe and Mail
Hims & Hers Drops 29.4% Over Three Months: What’s the Best Strategy for This Stock? - Bitget
Telehealth Kiosk Market Set to Witness Rapid Growth Through 2033 - openPR.com
A Look At Teladoc Health’s (TDOC) Valuation After Analyst Upgrades And Earnings Surprise - Yahoo Finance
Teladoc Health continues Rise tour as employees share impacts - Traders Union
Teladoc (TDOC) Falls More Steeply Than Broader Market: What Investors Need to Know - Yahoo Finance Singapore
[144] Teladoc Health, Inc. SEC Filing - Stock Titan
Stock Market Gains: nLIGHT, Vertex, Teladoc Rise on NewsNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Stocks making big moves yesterday: nLIGHT, Myriad Genetics, Vertex Pharmaceuticals, Nextpower, and Teladoc - Yahoo Finance
Virtual Visits Market Is Going to Boom Rapidly | Teladoc Health Inc., American Well Corporation - openPR.com
Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook - AOL.com
Teladoc (TDOC) Surges 5.1%: Is This an Indication of Further Gains? - Yahoo! Finance Canada
Virtual Care Market Is Going to Boom Rapidly | Teladoc Health Inc., American Well Corporation - openPR.com
Teladoc at Barclays Conference: Strategic Shifts and AI Focus - Investing.com
Why Teladoc (TDOC) Stock Is Up Today - Finviz
TDOC: Deutsche Bank Upgrades Teladoc Health to 'Buy' with New Pr - GuruFocus
텔라닥 헬스 (TDOC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):